American Healthcare REIT (NYSE:AHR) Price Target Raised to $65.00

Posted by Francis Steltz on Jul 30th, 2026

American Healthcare REIT (NYSE:AHR – Free Report) had its price objective increased by Citizens Jmp from $60.00 to $65.00 in a report published on Monday,Benzinga reports. They currently have a market outperform rating on the stock.

Several other equities analysts also recently issued reports on the stock. UBS Group lifted their price target on shares of American Healthcare REIT from $60.00 to $63.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Royal Bank Of Canada upped their price objective on shares of American Healthcare REIT from $54.00 to $56.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Scotiabank dropped their price objective on shares of American Healthcare REIT from $59.00 to $51.00 and set a “sector outperform” rating for the company in a report on Thursday, June 18th. Barclays assumed coverage on shares of American Healthcare REIT in a research note on Tuesday, July 7th. They issued an “overweight” rating and a $61.00 target price for the company. Finally, Compass Point started coverage on American Healthcare REIT in a report on Tuesday, July 21st. They issued a “buy” rating and a $70.00 target price on the stock. Twelve investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, American Healthcare REIT currently has a consensus rating of “Moderate Buy” and a consensus price target of $58.83.

Get Our Latest Stock Report on AHR

American Healthcare REIT Stock Performance

Shares of NYSE:AHR opened at $57.61 on Monday. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.45 and a quick ratio of 0.45. The business’s fifty day moving average price is $51.42 and its two-hundred day moving average price is $50.34. American Healthcare REIT has a fifty-two week low of $37.66 and a fifty-two week high of $58.70. The stock has a market capitalization of $11.10 billion, a price-to-earnings ratio of 99.33, a price-to-earnings-growth ratio of 1.93 and a beta of 0.77.

American Healthcare REIT (NYSE:AHR – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.34). American Healthcare REIT had a net margin of 4.23% and a return on equity of 3.33%. The company had revenue of $650.77 million for the quarter, compared to the consensus estimate of $667.57 million. During the same period in the previous year, the business posted $0.38 earnings per share. The firm’s revenue was up 20.4% compared to the same quarter last year. American Healthcare REIT has set its FY 2026 guidance at 2.030-2.090 EPS. As a group, analysts predict that American Healthcare REIT will post 2.07 EPS for the current fiscal year.

American Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, July 17th. Investors of record on Tuesday, June 30th were given a dividend of $0.25 per share. The ex-dividend date was Tuesday, June 30th. This represents a $1.00 annualized dividend and a yield of 1.7%. American Healthcare REIT’s dividend payout ratio is 172.41%.

Insider Transactions at American Healthcare REIT

In other American Healthcare REIT news, CFO Brian Peay sold 25,000 shares of the firm’s stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $50.70, for a total value of $1,267,500.00. Following the completion of the sale, the chief financial officer owned 152,700 shares in the company, valued at approximately $7,741,890. This trade represents a 14.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Mark E. Foster sold 2,500 shares of the business’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $48.58, for a total transaction of $121,450.00. Following the completion of the transaction, the executive vice president directly owned 52,995 shares of the company’s stock, valued at approximately $2,574,497.10. This represents a 4.50% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 29,500 shares of company stock worth $1,485,590. Insiders own 0.75% of the company’s stock.

Institutional Trading of American Healthcare REIT

Hedge funds and other institutional investors have recently modified their holdings of the stock. Manning & Napier Advisors LLC bought a new position in American Healthcare REIT in the 1st quarter worth approximately $26,000. Garton & Associates Financial Advisors LLC acquired a new position in American Healthcare REIT during the 4th quarter worth $26,000. Kemnay Advisory Services Inc. bought a new position in American Healthcare REIT in the 4th quarter valued at $29,000. Los Angeles Capital Management LLC bought a new position in American Healthcare REIT in the 4th quarter valued at $34,000. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in shares of American Healthcare REIT in the 4th quarter valued at $35,000. Institutional investors and hedge funds own 16.68% of the company’s stock.

American Healthcare REIT Company Profile

(Get Free Report)

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.